Your browser doesn't support javascript.
loading
A potent synthetic nanobody with broad-spectrum activity neutralizes SARS-CoV-2 virus and the Omicron variant BA.1 through a unique binding mode.
Zhao, Dongping; Liu, Liqin; Liu, Xinlin; Zhang, Jinlei; Yin, Yuqing; Luan, Linli; Jiang, Dingwen; Yang, Xiong; Li, Lei; Xiong, Hualong; Xing, Dongming; Zheng, Qingbing; Xia, Ningshao; Tao, Yuyong; Li, Shaowei; Huang, Haiming.
Afiliação
  • Zhao D; Qingdao Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao, 266071, China.
  • Liu L; Noventi Biopharmaceuticals Co., Ltd, Shanghai, 201203, China.
  • Liu X; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, School of Life Sciences, Xiamen University, Xiamen, 361102, China.
  • Zhang J; National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, 361102, China.
  • Yin Y; Qingdao Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao, 266071, China.
  • Luan L; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, School of Life Sciences, Xiamen University, Xiamen, 361102, China.
  • Jiang D; Noventi Biopharmaceuticals Co., Ltd, Shanghai, 201203, China.
  • Yang X; Noventi Biopharmaceuticals Co., Ltd, Shanghai, 201203, China.
  • Li L; Noventi Biopharmaceuticals Co., Ltd, Shanghai, 201203, China.
  • Xiong H; Guangxi Asia United Antibody Medical Co., Ltd, Hezhou, 542899, Guangxi, China.
  • Xing D; Qingdao Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao, 266071, China.
  • Zheng Q; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, School of Life Sciences, Xiamen University, Xiamen, 361102, China.
  • Xia N; Qingdao Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao, 266071, China.
  • Tao Y; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, School of Life Sciences, Xiamen University, Xiamen, 361102, China.
  • Li S; National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, 361102, China.
  • Huang H; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, School of Life Sciences, Xiamen University, Xiamen, 361102, China.
J Nanobiotechnology ; 20(1): 411, 2022 Sep 15.
Article em En | MEDLINE | ID: mdl-36109732
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Anticorpos de Domínio Único / SARS-CoV-2 / Anticorpos Antivirais Idioma: En Revista: J Nanobiotechnology Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Anticorpos de Domínio Único / SARS-CoV-2 / Anticorpos Antivirais Idioma: En Revista: J Nanobiotechnology Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido